The high blood pressure medication Benicar will face generic competition this year, effectively ending its longstanding stranglehold on the market. However, manufacturer Daiichi Sankyo’s trouble with Benicar is merely...
Last month, a judge overseeing the Benicar multidistrict litigation (MDL) ruled European executives would not have to testify in Benicar lawsuits filed in the United States. This came as...
Pharmaceutical giant Mylan recently announced it received FDA approval of a generic version of Daiichi Sankyo’s blood pressure medication Benicar. Mylan likely hopes its version doesn’t face the harsh...
As the Benicar litigation moves slowly toward 2017 bellwether trial dates, a New Jersey judge decided European executives from Daiichi Sankyo will not need to testify in the upcoming...
In July 2013, the U.S. Food and Drug Administration (FDA) issued a warning to patients and doctors that the popular blood pressure medication Benicar had been linked to a...
Japan-based pharmaceutical giant Daiichi Sankyo faces a slew of lawsuits in the U.S. over the company’s popular blood pressure medication, Benicar. While the company has faced Benicar lawsuits for...
As the Benicar litigation slowly moves closer to trial, additional lawsuits are quickly taking off. Benicar’s manufacturer, Daiichi Sankyo, now faces nearly 1,700 lawsuits alleging it failed to warn...
Allen Williamson began taking the popular medication Benicar to help him manage his high blood pressure. Although he was taking the recommended dosage of Benicar, Mr. Williamson began experiencing...
Plaintiffs in the Benicar litigation were dealt a blow earlier this week when the first bellwether trial dates were pushed back to 2017. The trials were originally scheduled to...
The popular high blood pressure medication Benicar is currently facing 1,239 lawsuits alleging the manufacturer failed to warn patients of the serious side effects associated with the drug.
